Concourse Financial Group Securities, Inc. Crispr Therapeutics Ag Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 269 shares of CRSP stock, worth $13,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
269
Previous 203
32.51%
Holding current value
$13,312
Previous $13,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$389 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$385 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$156 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$156 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$137 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.86B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....